Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy

被引:2
|
作者
Esen, Ebru [1 ]
Sizmaz, Selcuk [1 ]
Demircan, Nihal [1 ]
机构
[1] Cukurova Univ, Sch Med, Dept Ophthalmol, Adana, Turkey
关键词
Central serous chorioretinopathy; Photodynamic therapy; Optical coherence tomography; Outer nuclear layer; Choroidal thickness; OPTICAL COHERENCE TOMOGRAPHY; SUBFOVEAL CHOROIDAL THICKNESS; PHOTORECEPTOR OUTER SEGMENT; MORPHOLOGIC CHANGES; NUCLEAR LAYER; VERTEPORFIN; EYES; OUTCOMES;
D O I
10.1016/j.pdpdt.2021.102347
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To evaluate the retinal and choroidal microstructural changes at fovea after half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC), using optical coherence tomography (OCT). Methods: The study included 35 eyes with unilateral chronic CSC treated with half-dose PDT. The foveal outer nuclear layer (ONL) and subfoveal choroidal thickness (SFCT) in the affected eyes were compared with baseline measurements at month 1, 3, and 6 after half-dose PDT, and those of the healthy contralateral eyes. Results: The mean baseline ONL thickness of the affected eyes was thinner compared to unaffected fellow eyes (66.9 +/- 16.5 mu m vs 111.5 +/- 11.6 mu m, p<0.001), and increased significantly to 68.6 +/- 17.0 mu m at month 3 and 68.9 +/- 17.3 mu m at month 6 after treatment (p = 0.025 and p = 0.014 respectively). The mean baseline SFCT of the affected eyes was thicker compared to unaffected fellow eyes (399.9 +/- 87.0 mu m vs 338.2 +/- 75.4 mu m, p<0.001), and decreased significantly after treatment at month 1, 3, and 6 (374.0 +/- 84.8 mu m, 369.7 +/- 81.8 mu m, 367.3 +/- 80.8 mu m respectively, p<0.001 for all). The responder group (n = 26), in which subretinal fluid was completely resorbed, showed a significant increase in ONL thickness and decrease in SFCT after treatment, whereas in the non-responder group (n = 9) ONL thickness and SFCT did not differ after treatment. Conclusions: In CSC patients, significant changes are observed in foveal ONL thickness and SFCT after half-dose PDT. ONL thickness and SFCT are suggested to be considered in the OCT examinations of CSC patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [11] Half-Fluence Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Nicolo, Massimo
    Eandi, Chiara M.
    Alovisi, Camilla
    Grignolo, Federico M.
    Traverso, Carlo Enrico
    Musetti, Donatella
    Piccolino, Felice Cardillo
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 157 (05) : 1033 - 1037
  • [12] Half-dose versus half-fluence photodynamic therapy for chronic central serous chorioretinopathy
    Matoba, Ryo
    Shiode, Yusuke
    Kawata, Tetsuhiro
    Hosokawa, Mio
    Kimura, Shuhei
    Morizane, Yuki
    Shiraga, Fumio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [13] Experiences with chronic central serous chorioretinopathy treated with half-dose photodynamic therapy and verteporfin
    Toeteberg-Harms, M.
    Kurz-Levin, M.
    Fleischhauer, J.
    Windisch, R.
    OPHTHALMOLOGE, 2011, 108 (10): : 947 - 951
  • [14] Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
    Sanguansak, Thuss
    Pitujaturont, Prapapan
    Yospaiboon, Yosanan
    Sinawat, Suthasinee
    Ratanapakorn, Tanapat
    Bhoomibunchoo, Chavakij
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 2257 - 2261
  • [15] Half-Dose Verteporfin Combined with Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
    Liu, Chun-Fu
    Chen, Lee-Jen
    Tsai, Shawn H.
    Lai, Chi-Chun
    Chan, Wei-Chun
    Wu, Wei-Chi
    Wang, Nan-Kai
    Chen, Kuan-Jen
    Hwang, Yih-Shiou
    Chen, Yen-Po
    Yeung, Ling
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 30 (05) : 400 - 405
  • [16] Half-fluence Versus Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy REPLY
    Nicolo, Massimo
    Traverso, Carlo Enrico
    Musetti, Donatella
    Piccolino, Felice Cardillo
    Eandi, Chiara M.
    Alovisi, Camilla
    Grignolo, Federico M.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 159 (01) : 205 - 206
  • [17] No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
    Andrea Servillo
    Riccardo Sacconi
    Ilaria Zucchiatti
    Elena Grachova
    Lea Querques
    Francesco Prascina
    Beatrice Tombolini
    Giorgio Dorin
    Martin Mainster
    Francesco Bandello
    Giuseppe Querques
    Ophthalmology and Therapy, 2023, 12 : 2199 - 2208
  • [18] No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
    Servillo, Andrea
    Sacconi, Riccardo
    Zucchiatti, Ilaria
    Grachova, Elena
    Querques, Lea
    Prascina, Francesco
    Tombolini, Beatrice
    Dorin, Giorgio
    Mainster, Martin
    Bandello, Francesco
    Querques, Giuseppe
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (04) : 2199 - 2208
  • [19] Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Cheng, Zhihang
    Babiker, Salma
    Lenfestey, Pauline
    Beare, Nick
    Pearce, Ian A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [20] Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy
    R Uetani
    Y Ito
    K Oiwa
    K Ishikawa
    H Terasaki
    Eye, 2012, 26 : 640 - 649